Blood-pressure and cholesterol lowering in persons without cardiovascular disease

12 p.

Autores:
Yusuf, Salim
Lonn, Eva
Pais, Prem
Bosch, Jackie
Lopez-Jaramillo, Patricio
Zhu, Jun
Xavier, Denis
Avezum, Alvaro
Leiter, Lawrence A.
Piegas, Leopoldo S.
Parkhomenko, Alexander
Keltai, Matyas
Keltai, Katalin
Sliwa, Karen
Chazova, Irina
Peters, Ron J.G.
Held, Claes
Yusoff, Khalid
Lewis, Basil S.
Jansky, Petr
Khunti, Kamlesh
Toff, William D.
Reid, Christopher M.
Varigos, John
Accini, Jose Luis
McKelvie, Robert
Pogue, Janice
Jung, Hyejung
Liu, Lisheng
Diaz, Rafael
Dans, Antonio
Dagenais, Gilles
HOPE-3 Investigators
Tipo de recurso:
Article of journal
Fecha de publicación:
2016
Institución:
Universidad de Santander
Repositorio:
Repositorio Universidad de Santander
Idioma:
eng
OAI Identifier:
oai:repositorio.udes.edu.co:001/3458
Acceso en línea:
https://repositorio.udes.edu.co/handle/001/3458
Palabra clave:
Blood pressure
Cholesterol lowering
Cardiovascular disease
Rights
closedAccess
License
Derechos Reservados - New England Journal of Medicine, 2016
id RUDES2_408a0a43ce3e55606ddbbf429ebbe210
oai_identifier_str oai:repositorio.udes.edu.co:001/3458
network_acronym_str RUDES2
network_name_str Repositorio Universidad de Santander
repository_id_str
dc.title.eng.fl_str_mv Blood-pressure and cholesterol lowering in persons without cardiovascular disease
title Blood-pressure and cholesterol lowering in persons without cardiovascular disease
spellingShingle Blood-pressure and cholesterol lowering in persons without cardiovascular disease
Blood pressure
Cholesterol lowering
Cardiovascular disease
title_short Blood-pressure and cholesterol lowering in persons without cardiovascular disease
title_full Blood-pressure and cholesterol lowering in persons without cardiovascular disease
title_fullStr Blood-pressure and cholesterol lowering in persons without cardiovascular disease
title_full_unstemmed Blood-pressure and cholesterol lowering in persons without cardiovascular disease
title_sort Blood-pressure and cholesterol lowering in persons without cardiovascular disease
dc.creator.fl_str_mv Yusuf, Salim
Lonn, Eva
Pais, Prem
Bosch, Jackie
Lopez-Jaramillo, Patricio
Zhu, Jun
Xavier, Denis
Avezum, Alvaro
Leiter, Lawrence A.
Piegas, Leopoldo S.
Parkhomenko, Alexander
Keltai, Matyas
Keltai, Katalin
Sliwa, Karen
Chazova, Irina
Peters, Ron J.G.
Held, Claes
Yusoff, Khalid
Lewis, Basil S.
Jansky, Petr
Khunti, Kamlesh
Toff, William D.
Reid, Christopher M.
Varigos, John
Accini, Jose Luis
McKelvie, Robert
Pogue, Janice
Jung, Hyejung
Liu, Lisheng
Diaz, Rafael
Dans, Antonio
Dagenais, Gilles
HOPE-3 Investigators
dc.contributor.author.spa.fl_str_mv Yusuf, Salim
Lonn, Eva
Pais, Prem
Bosch, Jackie
Lopez-Jaramillo, Patricio
Zhu, Jun
Xavier, Denis
Avezum, Alvaro
Leiter, Lawrence A.
Piegas, Leopoldo S.
Parkhomenko, Alexander
Keltai, Matyas
Keltai, Katalin
Sliwa, Karen
Chazova, Irina
Peters, Ron J.G.
Held, Claes
Yusoff, Khalid
Lewis, Basil S.
Jansky, Petr
Khunti, Kamlesh
Toff, William D.
Reid, Christopher M.
Varigos, John
Accini, Jose Luis
McKelvie, Robert
Pogue, Janice
Jung, Hyejung
Liu, Lisheng
Diaz, Rafael
Dans, Antonio
Dagenais, Gilles
HOPE-3 Investigators
dc.subject.proposal.eng.fl_str_mv Blood pressure
Cholesterol lowering
Cardiovascular disease
topic Blood pressure
Cholesterol lowering
Cardiovascular disease
description 12 p.
publishDate 2016
dc.date.issued.spa.fl_str_mv 2016-04-02
dc.date.accessioned.spa.fl_str_mv 2019-07-24T16:33:32Z
dc.date.available.spa.fl_str_mv 2019-07-24T16:33:32Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.spa.fl_str_mv 10.1056/NEJMoa1600177
dc.identifier.issn.spa.fl_str_mv 1533-4406
0028-4793
dc.identifier.uri.spa.fl_str_mv https://repositorio.udes.edu.co/handle/001/3458
identifier_str_mv 10.1056/NEJMoa1600177
1533-4406
0028-4793
url https://repositorio.udes.edu.co/handle/001/3458
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartof.eng.fl_str_mv New England Journal of Medicine
dc.rights.spa.fl_str_mv Derechos Reservados - New England Journal of Medicine, 2016
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_14cb
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0/
rights_invalid_str_mv Derechos Reservados - New England Journal of Medicine, 2016
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
https://creativecommons.org/licenses/by-nc/4.0/
http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.source.eng.fl_str_mv https://pdfs.semanticscholar.org/5673/95a89b91b2364dd49deb534e92047b9a0fd6.pdf?_ga=2.229909532.1207694793.1563984236-1782380525.1556661431
https://www.nejm.org/doi/pdf/10.1056/NEJMx180035?articleTools=true
institution Universidad de Santander
bitstream.url.fl_str_mv https://repositorio.udes.edu.co/bitstreams/94582f50-6be7-4e13-808e-95d869a7aaa5/download
https://repositorio.udes.edu.co/bitstreams/8a2d969c-3815-4127-85ee-60ce4532d33b/download
https://repositorio.udes.edu.co/bitstreams/e9341380-25c6-4fe5-a5e2-ac4bf469ba1c/download
https://repositorio.udes.edu.co/bitstreams/3b79fcde-a852-497d-8335-3729c5d62498/download
https://repositorio.udes.edu.co/bitstreams/4af53503-7e51-4508-a8ab-4b5c88d33c77/download
https://repositorio.udes.edu.co/bitstreams/255d6cd3-3095-4ba9-8dd8-e9e7adb387ce/download
https://repositorio.udes.edu.co/bitstreams/6e4bdcc3-9d0f-4ccd-bb85-8305565baa6d/download
bitstream.checksum.fl_str_mv 7c484dbbd5c4e915f593a9b2f02c887e
16e13b67784dc43d7444f6d3cb0e7269
8ee9208c6ef5dd6531023e73f912e416
dabe6ec07aa2bf07e1b2cacf0e9ed480
38d94cf55aa1bf2dac1a736ac45c881c
f6d9a32d36a19b1d38771fd856f47d26
84f99d08a035b85317d434ba05f219b5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Universidad de Santander
repository.mail.fl_str_mv soporte@metabiblioteca.com
_version_ 1814158747979743232
spelling Yusuf, Salim06a836b5-f5e3-41d9-a516-9cc46e5d7948-1Lonn, Eva7a977a4b-14e3-44cc-8057-933d424aaa9b-1Pais, Prem5abdbf77-3c3f-4396-8634-83723aa215b9-1Bosch, Jackie503f2202-0dda-463c-acc9-f5888e895278-1Lopez-Jaramillo, Patricio9a71267b-dcb0-4d31-b37d-2d30be58d4d2-1Zhu, Jund97cdbd2-6a82-430c-abfe-c978f085997e-1Xavier, Denis88c9cf48-fa3b-45c6-be03-2cc79e59289d-1Avezum, Alvaro8b920360-abb2-4ec8-b5ee-4e3f4e0b11eb-1Leiter, Lawrence A.bcdd3211-40b7-474d-9f6c-8a1051ceb9bf-1Piegas, Leopoldo S.0f1da4dd-76bd-4381-87fa-1e01066eee6f-1Parkhomenko, Alexander11fab1ea-f0f6-47e0-97e9-36e372b7e2f9-1Keltai, Matyas65c5da4f-dca6-4e4f-aa9e-6c2ff81f2df9-1Keltai, Kataline6748cb0-125e-4199-9d27-8f14335aec02-1Sliwa, Karen7ff2b80f-9412-4d65-99cd-7d01d5578687-1Chazova, Irinace6fc484-15aa-401c-a370-8afcad931907-1Peters, Ron J.G.43007a97-9e31-41a5-a7fc-ce7357bd484f-1Held, Claes76b69ce8-c468-49c5-8d48-95a823d8b565-1Yusoff, Khalid933db13d-f5bb-4ea6-91a5-68eea1ca9ffc-1Lewis, Basil S.a8106b8e-2b4b-412e-90c7-4012b1272405-1Jansky, Petrbf8ec62a-6edc-439c-a698-2e4fa4172f04-1Khunti, Kamleshe9aff03a-6f97-433d-a56e-8d7f703caa03-1Toff, William D.97acb6df-c33b-45ad-b772-c52ac4aa7281-1Reid, Christopher M.7d8a8211-12ad-464c-948d-16952b66144d-1Varigos, Johnedec3b03-87c5-454c-aec5-b2c04c91a9d9-1Accini, Jose Luis0a64fd59-b75f-432f-8268-d96da4646e86-1McKelvie, Robertb7cfc72e-3a56-4797-8848-d0db71a3ef50-1Pogue, Janiceda5c963c-440a-4bf6-981a-f2217b50fc1d-1Jung, Hyejung50f4ceae-59e5-4f12-9788-b713f56de3be-1Liu, Lishenga14adafe-ef37-42b0-8f5b-0de4ea71b0fc-1Diaz, Rafaelf2be4a74-501a-4e63-8bbd-965cbcf8c57b-1Dans, Antoniof365ef5a-7610-4022-8485-31d6d3879cd6-1Dagenais, Gillesc865f015-4dc7-483d-9dae-132288d901f8-1HOPE-3 Investigatorsad5cd98d-86e0-4739-a226-91ef50ed152c-12019-07-24T16:33:32Z2019-07-24T16:33:32Z2016-04-0212 p.BACKGROUND Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase the risk of cardiovascular disease. Lowering both should reduce the risk of cardiovascular events substantially. METHODS In a trial with 2-by-2 factorial design, we randomly assigned 12,705 participants at intermediate risk who did not have cardiovascular disease to rosuvastatin (10 mg perday) or placebo and to candesartan (16 mg per day) plus hydrochlorothiazide (12.5 mg per day) or placebo. In the analyses reported here, we compared the 3180 participants assigned to combined therapy (with rosuvastatin and the two antihypertensive agents) with the 3168 participants assigned to dual placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, and the second coprimary outcome additionally included heart failure, cardiac arrest, or revascularization. The median follow-up was 5.6 years. RESULTS The decrease in the LDL cholesterol level was 33.7 mg per deciliter (0.87 mmol per liter) greater in the combined-therapy group than in the dual-placebo group, and the decrease in systolic blood pressure was 6.2 mm Hg greater with combined therapy than with dual placebo. The first coprimary outcome occurred in 113 participants (3.6%) in the combined-therapy group and in 157 (5.0%) in the dual-placebo group (hazard ratio, 0.71; 95% confidence interval [CI], 0.56 to 0.90; P=0.005). The second coprimary outcome occurred in 136 participants (4.3%) and 187 participants (5.9%), respectively (hazard ratio, 0.72; 95% CI, 0.57 to 0.89; P=0.003). Muscle weakness and dizziness were more common in the combined-therapy group than in the dual-placebo group, but the overall rate of discontinuation of the trial regimen was similar in the two groups. CONCLUSIONS The combination of rosuvastatin (10 mg per day), candesartan (16 mg per day), and hydrochlorothiazide (12.5 mg per day) was associated with a significantly lower rate of cardiovascular events than dual placebo among persons at intermediate risk who did not have cardiovascular disease. (Funded by the Canadian Institutes of Health Research and AstraZeneca; ClinicalTrials.gov number, NCT00468923.)application/pdf10.1056/NEJMoa16001771533-44060028-4793https://repositorio.udes.edu.co/handle/001/3458engNew England Journal of MedicineDerechos Reservados - New England Journal of Medicine, 2016info:eu-repo/semantics/closedAccessAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/http://purl.org/coar/access_right/c_14cbhttps://pdfs.semanticscholar.org/5673/95a89b91b2364dd49deb534e92047b9a0fd6.pdf?_ga=2.229909532.1207694793.1563984236-1782380525.1556661431https://www.nejm.org/doi/pdf/10.1056/NEJMx180035?articleTools=trueBlood pressureCholesterol loweringCardiovascular diseaseBlood-pressure and cholesterol lowering in persons without cardiovascular diseaseArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85PublicationTHUMBNAILBlood-pressure and cholesterol lowering in persons without cardiovascular disease.pdf.jpgBlood-pressure and cholesterol lowering in persons without cardiovascular disease.pdf.jpgGenerated Thumbnailimage/jpeg1684https://repositorio.udes.edu.co/bitstreams/94582f50-6be7-4e13-808e-95d869a7aaa5/download7c484dbbd5c4e915f593a9b2f02c887eMD56Blood-pressure and cholesterol lowering in persons without cardiovascular disease. Correction.pdf.jpgBlood-pressure and cholesterol lowering in persons without cardiovascular disease. Correction.pdf.jpgGenerated Thumbnailimage/jpeg1720https://repositorio.udes.edu.co/bitstreams/8a2d969c-3815-4127-85ee-60ce4532d33b/download16e13b67784dc43d7444f6d3cb0e7269MD57TEXTBlood-pressure and cholesterol lowering in persons without cardiovascular disease.pdf.txtBlood-pressure and cholesterol lowering in persons without cardiovascular disease.pdf.txtExtracted texttext/plain51359https://repositorio.udes.edu.co/bitstreams/e9341380-25c6-4fe5-a5e2-ac4bf469ba1c/download8ee9208c6ef5dd6531023e73f912e416MD54Blood-pressure and cholesterol lowering in persons without cardiovascular disease. Correction.pdf.txtBlood-pressure and cholesterol lowering in persons without cardiovascular disease. Correction.pdf.txtExtracted texttext/plain7165https://repositorio.udes.edu.co/bitstreams/3b79fcde-a852-497d-8335-3729c5d62498/downloaddabe6ec07aa2bf07e1b2cacf0e9ed480MD55LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/4af53503-7e51-4508-a8ab-4b5c88d33c77/download38d94cf55aa1bf2dac1a736ac45c881cMD53ORIGINALBlood-pressure and cholesterol lowering in persons without cardiovascular disease. Correction.pdfBlood-pressure and cholesterol lowering in persons without cardiovascular disease. Correction.pdfCorrección Documento Principalapplication/pdf54984https://repositorio.udes.edu.co/bitstreams/255d6cd3-3095-4ba9-8dd8-e9e7adb387ce/downloadf6d9a32d36a19b1d38771fd856f47d26MD52Blood-pressure and cholesterol lowering in persons without cardiovascular disease.pdfBlood-pressure and cholesterol lowering in persons without cardiovascular disease.pdfapplication/pdf255708https://repositorio.udes.edu.co/bitstreams/6e4bdcc3-9d0f-4ccd-bb85-8305565baa6d/download84f99d08a035b85317d434ba05f219b5MD58001/3458oai:repositorio.udes.edu.co:001/34582023-10-10 08:40:32.427https://creativecommons.org/licenses/by-nc/4.0/Derechos Reservados - New England Journal of Medicine, 2016https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo=